Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
131.87B
Market cap131.87B
Price-Earnings ratio
34.42
Price-Earnings ratio34.42
Dividend yield
0.76%
Dividend yield0.76%
Average volume
4.02M
Average volume4.02M
High today
$187.79
High today$187.79
Low today
$181.72
Low today$181.72
Open price
$182.00
Open price$182.00
Volume
2.79M
Volume2.79M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$160.93
52 Week low$160.93

Stock Snapshot

Danaher(DHR) stock is priced at $186.32, giving the company a market capitalization of 131.87B. It carries a P/E multiple of 34.42 and pays a dividend yield of 76.4%.

During the trading session on 2026-06-04, Danaher(DHR) shares reached a daily high of $187.79 and a low of $181.72. At a current price of $186.32, the stock is +2.5% higher than the low and still -0.8% under the high.

Trading volume for Danaher(DHR) stock has reached 2.79M, versus its average volume of 4.02M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $160.93.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $160.93.

DHR News

TipRanks 19h
Danaher Completes Multi-Tranche Swiss Franc Notes Offering

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

MarketWatch 20h
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch

...

Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
TipRanks 1d
Danaher price target lowered to $230 from $270 at HSBC

HSBC lowered the firm’s price target on Danaher (DHR) to $230 from $270 and keeps a Buy rating on the shares. The firm says market expectations on life science...

Analyst ratings

89%

of 28 ratings
Buy
89.3%
Hold
10.7%
Sell
0%

More DHR News

TipRanks 1d
Danaher initiated with a Buy at DZ Bank

DZ Bank initiated coverage of Danaher (DHR) with a Buy rating and $210 price target Published first on TheFly – the ultimate source for real-time, market-movin...

Simply Wall St 2d
What Danaher's New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders

In recent days, SCIEX, a Danaher company, announced platform-wide upgrades to its accurate mass ZenoTOF line and unveiled the novus V55 next-generation triple q...

What Danaher's New AI-Enabled SCIEX Mass Spec Platform Means For Shareholders
TipRanks 3d
Danaher assumed with Peer Perform at Wolfe Research

As previously reported, Wolfe Research analyst Mike Polark downgraded Danaher (DHR) to Peer Perform from Outperform with no price target after assuming coverage...

Simply Wall St 4d
Is It Time To Revisit Danaher After Recent Life Sciences Focus And Price Rebound

If you are wondering whether Danaher stock at around US$182.67 still offers value, or if the recent move has already priced in the key stories, this article bre...

Is It Time To Revisit Danaher After Recent Life Sciences Focus And Price Rebound
Simply Wall St 6d
A Look At Danaher Valuation After RBC Capital Resumes Coverage With Bioprocess Recovery Outlook

Advertisement RBC coverage restart puts Danaher (DHR) bioprocess outlook back in focus RBC Capital’s decision to resume coverage of Danaher (DHR), pointing to...

A Look At Danaher Valuation After RBC Capital Resumes Coverage With Bioprocess Recovery Outlook

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.